Cite
HARVARD Citation
Koltowski, L. et al. (2020). Second generation, sirolimus‐eluting, bioresorbable Tyrocore scaffold implantation in patients with ST‐segment elevation myocardial infarction: Baseline OCT and 30‐day clinical outcomes – A FANTOM STEMI pilot study. Catheterization and cardiovascular interventions. 96 (1), pp. E1-E7. [Online].